Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

The National Institute for Health and Care Excellence (NICE) invited Alimera Sciences, the company manufacturing fluocinolone acetonide intravitreal implant (FAc) 0.19 mg (tradename ILUVIEN(®)), to submit evidence on the clinical and cost-effectiveness of FAc for treating recurrent non-infectious uv...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Pharmacoeconomics
Autores principales: Pouwels, Xavier G. L. V., Petersohn, Svenja, Carrera, Vanesa Huertas, Denniston, Alastair K., Chalker, Annette, Raatz, Heike, Armstrong, Nigel, Shah, Dhwani, Witlox, Willem, Worthy, Gill, Noake, Caro, Riemsma, Rob, Kleijnen, Jos, Joore, Manuela A.
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer International Publishing 2019
Materias:
Review Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7176320/
https://ncbi.nlm.nih.gov/pubmed/31701471
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-019-00851-z
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares